Senses Disorder TRIZ Cases

Catalytic transfer hydrogenation converts ketone precursors into trans-hydroxy sulfones using formic acid and chiral ruthenium complexes.

1,3,4-Oxadiazole amide derivatives inhibit histone deacetylase 6 through specific structural modifications.

IdeS polypeptide cleaves pathogenic IgG antibodies into inactive fragments, resolving inadequate treatment efficacy in autoimmune conditions.

Reversible carboxamide inhibitors reduce toxicity while maintaining high calpain selectivity.

Chimeric channelrhodopsins combine microbial and mammalian domains to resolve low sensitivity and slow kinetics in optogenetic treatments.

A sustained release dexamethasone formulation in triethyl acetyl citrate injects into the anterior chamber to deliver anti-inflammatory therapy.

Segmenting the IL-10 sequence at position 129 eliminates cell proliferative side effects while preserving therapeutic efficacy for neuropathic pain.

Lactobacillus paracasei strain LT12 balances Th1 and Th2 activities to inhibit allergic reactions.

Expand Lgr5+ inner ear supporting cells and differentiate them into functional hair cells using targeted signaling agents.

A gem-difluorinated C-glycopeptide compound protects neurosensory precursor cells before transplantation.

Selective phenyl derivatives bind cannabinoid receptor 2 to reduce inflammation while minimizing central nervous system side effects.

High-voltage electrical fields ionize fluid on a filament to produce nano-sized charged droplets, eliminating nozzle clogging from precipitants.

Qi611S protein degrades exopolysaccharide biofilm matrices, exposing embedded pathogens to host immunity and overcoming antibiotic resistance.

Targeted inhibitors prevent Alu RNA-induced cytotoxicity and geographic atrophy by blocking MyD88 signaling and IL-18 activation in retinal cells.

Replacing fetal bovine serum with defined synthetic components achieves GMP compliance while maintaining retinal differentiation efficiency.

Nucleic acid expression construct encoding human alpha-galactosidase fused with Arabidopsis ABPI signal peptide for plant cell production.

Injectable human collagen and elastin compositions provide soft tissue augmentation using isolated proteins from engineered vascular tissues.

Chimeric peptides integrate cell-permeable sequences with JNK inhibitors to overcome delivery barriers and reduce intraocular inflammation.

Novel sweet taste enhancers modulate chemosensory receptors to deliver improved sweetness profiles in ingestible compositions.

Small molecule compounds modulate cystic fibrosis transmembrane conductance regulator activity to enhance chloride and bicarbonate transport across epithelial cells.

Fluorescent tags enable direct quantification of covalent inhibitor conjugates, resolving the trade-off between irreversible binding and therapeutic monitoring.

A urethanedi(meth)acrylate composition with aromatic and aliphatic monomers enables controlled photopolymerization kinetics.

Engineered disulfide bonds covalently link polypeptide chains in bispecific diabodies, resolving rapid circulation clearance and enhancing therapeutic efficacy.